MC
IBB icon

Martin & Co’s iShares Biotechnology ETF IBB Stock Holding History

Martin & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4M Buy
21,024
+18
+0.1% +$3.09K 0.62% 47
2026
Q1 		$3.55M Buy
21,006
+257
+1% +$43.9K 0.6% 51
2025
Q4 		$3.5M Buy
20,749
+542
+3% +$88K 0.6% 48
2025
Q3 		$2.92M Sell
20,207
-11
-0.1% -$1.5K 0.52% 59
2025
Q2 		$2.56M Buy
20,218
+79
+0.4% +$9.7K 0.47% 63
2025
Q1 		$2.58M Buy
20,139
+814
+4% +$110K 0.5% 62
2024
Q4 		$2.55M Sell
19,325
-923
-5% -$130K 0.63% 62
2024
Q3 		$2.95M Buy
20,248
+32
+0.2% +$4.63K 0.69% 55
2024
Q2 		$2.77M Sell
20,216
-110
-0.5% -$14.7K 0.7% 52
2024
Q1 		$2.79M Sell
20,326
-657
-3% -$89.7K 0.68% 55
2023
Q4 		$2.85M Sell
20,983
-892
-4% -$109K 0.7% 51
2023
Q3 		$2.68M Sell
21,875
-123
-0.6% -$15.6K 0.7% 50
2023
Q2 		$2.79M Sell
21,998
-609
-3% -$79.1K 0.71% 49
2023
Q1 		$2.92M Sell
22,607
-509
-2% -$66.6K 0.75% 49
2022
Q4 		$3.03M Buy
23,116
+341
+1% +$44.1K 0.8% 49
2022
Q3 		$2.66M Buy
22,775
+453
+2% +$56.3K 0.79% 48
2022
Q2 		$2.63M Buy
22,322
+870
+4% +$103K 0.75% 47
2022
Q1 		$2.79M Sell
21,452
-1,891
-8% -$246K 0.71% 48
2021
Q4 		$3.56M Sell
23,343
-7,135
-23% -$1.1M 0.81% 40
2021
Q3 		$4.93M Buy
30,478
+2,725
+10% +$459K 1.16% 28
2021
Q2 		$4.54M Sell
27,753
-1,720
-6% -$265K 1.13% 30
2021
Q1 		$4.44M Sell
29,473
-408
-1% -$64.8K 1.12% 29
2020
Q4 		$4.53M Buy
29,881
+110
+0.4% +$15.7K 1.16% 29
2020
Q3 		$4.03M Sell
29,771
-215
-0.7% -$29.2K 1.18% 27
2020
Q2 		$4.1M Sell
29,986
-719
-2% -$91.7K 1.27% 24
2020
Q1 		$3.31M Buy
30,705
+1,072
+4% +$123K 1.18% 27
2019
Q4 		$3.57M Sell
29,633
-2,610
-8% -$291K 1.03% 32
2019
Q3 		$3.21M Sell
32,243
-1,220
-4% -$128K 0.97% 33
2019
Q2 		$3.65M Sell
33,463
-520
-2% -$55.3K 1.09% 30
2019
Q1 		$3.8M Sell
33,983
-1,705
-5% -$187K 1.15% 29
2018
Q4 		$3.44M Buy
35,688
+150
+0.4% +$15.9K 1.21% 22
2018
Q3 		$4.33M Sell
35,538
-325
-0.9% -$38.3K 1.31% 19
2018
Q2 		$3.94M Buy
35,863
+3,130
+10% +$335K 1.25% 20
2018
Q1 		$3.49M Buy
32,733
+1,768
+6% +$196K 1.16% 22
2017
Q4 		$3.31M Buy
30,965
+665
+2% +$71.1K 1.05% 31
2017
Q3 		$3.37M Sell
30,300
-2,610
-8% -$279K 1.1% 33
2017
Q2 		$3.4M Buy
32,910
+1,125
+4% +$111K 1.05% 36
2017
Q1 		$3.11M Buy
+31,785
New +$3.04M 0.99% 39

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Martin & Co's IBB Position: Q2 2026 in Review

Martin & Co increased its iShares Biotechnology ETF (IBB) stake by 0.09% in Q2 2026, buying an estimated $3.09K and bringing the position to 21,024 shares worth $4M. The position accounts for 0.62% of the portfolio, ranked #47.

Martin & Co first reported a position in IBB in Q1 2017 and has held it in 38 quarters since. The position peaked at $4.93M in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Martin & Co held 21,024 shares of iShares Biotechnology ETF worth $4M as of Q2 2026.
  • Martin & Co bought 18 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.09K.
  • iShares Biotechnology ETF made up 0.62% of Martin & Co's portfolio in Q2 2026, its #47 holding.
  • Martin & Co first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 38 quarters since.
  • Martin & Co's iShares Biotechnology ETF position peaked at $4.93M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Martin & Co's 13F filing for Q2 2026, filed 12 Aug 2026.